An interventional study of corticosteroids and biliary stent in Autoimmune Pancreatitis, IgG4-related Sclerosing Cholangitis and Obstructive Jaundice, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-14.
Sponsored by Peking Union Medical College Hospital · Not applicable, Interventional, and Treatment
This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.
Exclusion Criteria:
The patients will be treated with oral corticosteroids (prednisone 0.6mg/kg/d) alone.
Drug: corticosteroids
The patients will be treated with oral corticosteroids and biliary stent.
Drug: corticosteroids · Procedure: biliary stent
prednisone 0.6mg/kg/d
placement of biliary stent during endoscopic retrograde cholangiopancreatography (ERCP)
Clinical remission rate of obstructive jaundice
Time frame: Day 60
This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking Union Medical College Hospital